0314 GMT - IHH Healthcare's long-term prospects may remain optimistic, given its strategic plan for organic and inorganic growth, RHB IB analyst Oong Chun Sung says in a note. The healthcare service provider is targeting 4,000 new beds by 2028, with key expansion focussed on Malaysia and India, he notes. Oong cuts IHH's 2025-2026 earnings forecast by 3% and 1%, respectively, to factor in higher finance costs. RHB cuts IHH Healthcare's target price to MYR8.70 from MYR9.10 as its 2024 earnings came in below estimates, while maintaining a buy rating on the stock. Shares are 1.1% higher at MYR7.39. (yingxian.wong@wsj.com)
(END) Dow Jones Newswires
February 27, 2025 22:14 ET (03:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。